BAX

BAX Interest Expense

$292.00MTTM · USD

Period ending:

BAX FY Interest ExpenseUSD
BAX FY Interest Expense1985-12-31: $74.00M1986-12-31: $226.00M1987-12-31: $0.001988-12-31: $242.00M1989-12-31: $284.00M1990-12-31: $259.00M1991-12-31: $222.00M1992-12-31: $211.00M1993-12-31: $222.00M1994-12-31: $237.00M1995-12-31: $214.00M1996-12-31: $214.00M1997-12-31: $0.001998-12-31: $193.00M1999-12-31: $0.002000-12-31: $131.00M2001-12-31: $108.00M2002-12-31: $71.00M2003-12-31: $115.00M2004-12-31: $99.00M2005-12-31: $118.00M2006-12-31: $101.00M2007-12-31: $124.00M2008-12-31: $148.00M2009-12-31: $117.00M2010-12-31: $115.00M2011-12-31: $92.00M2012-12-31: $113.00M2013-12-31: $155.00M2014-12-31: $167.00M2015-12-31: $146.00M2016-12-31: $89.00M2017-12-31: $85.00M2018-12-31: $93.00M2019-12-31: $111.00M2020-12-31: $153.00M2021-12-31: $207.00M2022-12-31: $413.00M2023-12-31: $508.00M2024-12-31: $408.00M2025-12-31: $290.00M$508.00M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BAX interest expense history

Interest expense on outstanding debt. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Baxter International Interest Expense — Annual fiscal periods (USD)
Period endingInterest Expense (USD)
290,000,000
408,000,000
508,000,000
413,000,000
207,000,000
153,000,000
111,000,000
93,000,000
85,000,000
89,000,000
146,000,000
167,000,000
155,000,000
113,000,000
92,000,000
115,000,000
117,000,000
148,000,000
124,000,000
101,000,000
118,000,000
99,000,000
115,000,000
71,000,000
108,000,000
131,000,000
0
193,000,000
0
214,000,000
214,000,000
237,000,000
222,000,000
211,000,000
222,000,000
259,000,000
284,000,000
242,000,000
0
226,000,000
74,000,000

Compare interest expense

All BAX financial metrics · BAX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.